Feneptamidoquin identified by the developmental code SYN551769 exhibits fungicidal properties that prove highly effective in controlling phytopathogenic fungi. STATUS: Provisionally Approved Development…
Development
-
-
Agrochemical Discovery Candidates (New ISO)Agrochemicals
AGROCHEMICAL DISCOVERY UPDATE – SHANDONG UNITED PESTICIDE’S NEW FUNGICIDE FENOPYRAMID || GRANTED PROVISIONAL ISO STATUS
by adminby adminFenopyramid (LH-371), classified as a pyrazole compound, demonstrates effective control against soybean rust, corn rust, and wheat powdery mildew even when applied…
-
Agrochemical Discovery Candidates (New ISO)Agrochemicals
AGROCHEMICAL DISCOVERY UPDATE – CORTEVA AGRISCIENCE’S NEW INSECTICIDE TIAPYRACHLOR || GRANTED PROVISIONAL ISO STATUS
by adminby adminTiapyrachlor, identified by developmental codes such as X12019747, XR-120, & XDE-120, is a potent small molecule exhibiting efficacy against a diverse range…
-
2023 ApprovalsBiogenU.S FDA
August 2023 Approval Update: Sage and Biogen’s Zurzuvae™ (Zuranolone) notched FDA approval for the Treatment of Women with Postpartum Depression
by adminby adminThe U.S. Food and Drug Administration (FDA) on Friday approved Biogen and Sage Therapeutics oral pill to treat postpartum depression (PPD) in…
-
CompaniesPfizerRegulatoryU.S FDA
Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for relapsed or Refractory Multiple Myeloma
by adminby adminPfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for…
-
GskWHO
WHO Grants Prequalification to GSK’s Mosquirix – the first and only approved Malaria Vaccine
by adminby adminSummary: The World Health Organization (WHO) has awarded prequalification to Mosquirix, GSK’s malaria vaccine. This is the first prequalification for a malaria vaccine…
-
CompaniesMerger / AcquisitionPfizer
Pfizer to Acquire Global Blood Therapeutics in $5.4bn Deal
by adminby adminSummary : Through the acquisition of Global Blood Therapeutics, Pfizer aims to enhance its presence in rare haematology and particularly sickle cell…
-
CompaniesCovid DrugsPfizer
Pfizer and BioNTech aubmit for U.S. Emergency Use Authorization of an additional booster dose of their COVID-19 vaccine for older adults
by adminby adminSummary : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the companies have submitted an application to the U.S. Food…
-
Pharma Science & Research
Bill & Melinda Gates Foundation launch initiative for future pandemics
by adminby adminSummary : The initiative will catalyse discovery and early development of antiviral medicines for future pandemics The Novo Nordisk Foundation, Open Philanthropy…
-
Pharma Science & ResearchRoche
Roche’s Vabysmo to offer ‘fierce competition’ to Regeneron’s Eylea
by adminby adminSummary : Roche’s Vabysmo is having a strong start with doctors, but it has a long way to go if it wants…